3-Acetyl-7-Azaindole CAS 83393-46-8 - China Factory, Suppliers, Manufacturers

3-Acetyl-7-Azaindole CAS 83393-46-8, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...

2022.07.25 21:56:08
2022.05.20 11:06:29
2022.02.03 17:30:58
2021.12.11 18:40:08
2021.11.19 13:05:04
2021.10.20 05:43:49

3-Acetyl-7-Azaindole CAS 83393-46-8 - China Factory, Suppliers, Manufacturers

Related Products

3-Acetyl-7-Azaindole CAS 83393-46-8 Purity >99.0% (HPLC) Factory High Quality

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Alendronate Sodium Trihydrate CAS 121268-17-5 Assay (on Dried Basis) 98.0%~102.0%

4-Oxo-TEMPO Free Radical CAS 2896-70-0 Purity >95.0% (GC)

Ethyl (R)-(-)-Mandelate CAS 10606-72-1 Assay ≥98.0% Factory High Purity

Gatifloxacin CAS 112811-59-3 Purity >99.0% (HPLC)

(1R)-(-)-(10-Camphorsulfonyl)oxaziridine CAS 104372-31-8 Purity ≥98.5% High Purity

Ibrutinib CAS 936563-96-1 Purity >99.5% (HPLC) API

3-Amino-6-Chloropyridazine CAS 5469-69-2 Purity >99.5% (HPLC) Factory

4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS 220000-87-3 Sorafenib Tosylate Intermediate Factory High Purity

3,3′,5-Triiodo-L-Thyronine (Liothyronine; T3) CAS 6893-02-3 Purity >95.0% (HPLC) Factory

Xanthine; 2,6-Dihydroxypurine CAS 69-89-6 Assay ≥99.0% (HPLC) Factory

Boc-Asp(OBzl)-OH CAS 7536-58-5 Purity >99.0% (HPLC) Factory

4-Ethyl-5-Fluoro-6-Hydroxypyrimidine CAS 137234-87-8 Purity ≥99.0% (HPLC) Voriconazole Intermediate Factory

Paxlovid: what we know about Pfizer's Covid-19 pill

The “Summit on COVID-19 Diagnostics & Treatment”

Method Of Analyzing Palladium Content In Palladium Catalysts

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

2022.07.25 21:56:08

2022.05.20 11:06:29

2022.02.03 17:30:58

2021.12.11 18:40:08

2021.11.19 13:05:04

2021.10.20 05:43:49

related search